TIFFANY TERHUNE: Open Payments
NPI 1851838320 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 40 payments from 12 companies in 2025. Trend: 2023 $914 · 2024 $620 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 10 | $256 |
| Novo Nordisk Inc | 9 | $153 |
| Novartis Pharmaceuticals Corporation | 5 | $83 |
| Lilly USA, LLC | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
| Tandem Diabetes Care, Inc. | 2 | $45 |
| Abbott Laboratories | 2 | $33 |
| Medtronic, Inc. | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Insulet Corporation | 1 | $15 |
Products named: Dexcom G6 Transmitter, LEQVIO, Rybelsus, MOUNJARO, Kerendia, t:slim X2 Insulin Pump with Control-IQ, Wegovy, Ozempic.
Industry payments across OH — which companies pay providers there.
